WallStreetZenWallStreetZen

NASDAQ: VERV
Verve Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Verve Therapeutics revenue was $59.61M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $33.0M, up 152.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VERV annual revenue was $32.3M, with 175% growth year-over-year.

VERV past revenue growth

How has VERV's revenue growth performed historically?

Company
271.44%
Industry
1,361.15%
Market
34.96%
VERV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VERV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VERV's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VERV revenue history

Current Revenue
$59.6M
Current Earnings
-$181.0M
Current Profit Margin
-303.6%

Be the first to know when VERV announces revenue.

VERV Revenue History By Year

VERV Yearly RevenueVERV RevenueVERV ChangeVERV Revenue Growth
2024-12-31$32.33M$20.57M+174.98%
2023-12-31$11.76M$9.82M+505.77%
2022-12-31$1.94MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Verve Therapeutics Revenue FAQ

What was VERV's revenue last quarter?

Verve Therapeutics (NASDAQ: VERV) reported Q1 2025 revenue of $32.98 million up 479.03% year over year. In the same quarter last year, Verve Therapeutics's revenue was $5.70 million.

What was Verve Therapeutics's revenue in 2024?

Verve Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $32.33 million, a 174.98% increase year over year.

How much does Verve Therapeutics make in a day?

Based on Verve Therapeutics annual revenue for the past five years, VERV makes an average of $25,222.47 per day.

What was Verve Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Verve Therapeutics's revenue has grown 271.44% year over year. This is 1,089.7 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Verve Therapeutics's revenue in the past year totaled $59.61 million.

How much does Verve Therapeutics make in a year?

Verve Therapeutics's revenue by year for the past five years is:
  • Verve Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $32.33 million, a 174.98% increase year over year.
  • Verve Therapeutics's annual revenue for Dec 31, 2023 was $11.76 million, a 505.77% increase from 2022.
  • Verve Therapeutics's annual revenue for 2022 was $1.94 million, a Infinity% increase from 2021.
  • Verve Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Verve Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.